Ann M. Leen's Net Worth
Ann M. Leen has an <strong>estimated net worth of $7.06 Million dollars</strong>. This is based on reported shares across multiple companies, which include Allovir, Inc., and Marker Therapeutics, Inc..<br /><br />Ann M. Leen owns<strong>2,412,160 shares</strong> of Allovir, Inc.'s Common Stock which is worth $1,673,074.18 dollars. From 2020 to 2023 Ann M. Leen acquired a total of <strong>2,621,173 shares in Allovir, Inc.</strong>, Ann also disposed a total of <strong>269,407 shares of Allovir, Inc.</strong> equalling $5.39 Million.
Estimate Recalculated May 7, 2024 03:19PM EST
Who is Ann M. Leen?
SEC CIK
Ann M. Leen's CIK is 0001763026
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Allovir, Inc. (ALVR) No price found
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +74.83% | 81.01K |
—
|
—
| 189.26K |
Jan 18 - Feb 2
| |||
Form 4
| +53.57% | 15K |
—
|
—
| 43K |
Aug 16
| |||
Form 4
| -0.91% | -20.99K |
$22.18 | -$465,559.20 | 2.29M |
Scheduled
|
Nov 12 - Nov 16
| ||
Form 4
| -6.10% | -150.00K |
$22.75 | -$3,412,500.00 | 2.31M |
May 10
| |||
Form 4
| -0.12% | -3.02K |
$30.00 | -$90,750.91 | 2.46M |
Scheduled
|
Mar 16
| ||
Form 4
| -0.39% | -9.52K |
$38.70 | -$368,329.21 | 2.46M |
Scheduled
|
Mar 1
| ||
Form 4
| -0.70% | -17.45K |
$41.48 | -$723,624.58 | 2.47M |
Scheduled
|
Feb 19 - Feb 23
| ||
Form 4
| -0.11% | -2.70K |
$40.81 | -$110,194.24 | 2.49M |
Scheduled
|
Feb 18
| ||
Form 4
| -0.21% | -5.34K |
$41.27 | -$220,200.62 | 2.49M |
Scheduled
|
Feb 16 - Feb 17
| ||
Form 4
| +46.36% | 28K |
—
|
—
| 88.39K |
Nov 30 - Jan 19
| |||
Form 4
|
∞
| 2.44M |
—
|
—
| 2.44M |
Aug 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Marker Therapeutics, Inc. (MRKR) No price found
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |